Ibrutinib repurposing: From B-cell malignancies to solid tumors
Oxidative stress status in COVID-19 patients hospitalized in intensive care unit for severe pneumonia
Adarsh Ranganathan , Davide Tamburro, Alessandra Luchini, Emanuel F Petricoin III, Lance A Liotta, and Claudia Fredolini
But we can say that scientific opinion seems to lean more toward safe than unsafe. For example, in a 2021 Cognitive Vitality Report, the Alzheimers Drug Discovery Foundation points to a short-term study on CB4211 as some evidence for MOTS-cs safety.40 CB4211 is an analog, or synthetic version, of MOTS-c, and so it should theoretically pose a similar set of risks.41 The study in question was a double-blind, placebo-controlled trial in adult humans using both single doses and multiple ascending doses, under which protocol CB4211 was found to be safe and well tolerated.42 Side effects and potential health risks of MOTS-c Even if MOTS-c is as safe as CB4211, clinical researchers and the healthcare providers we know warn that it potentially poses specific health risks
